Anterior pituitary the secretion of thyroid-stimulating hormone (TSH). Prostaglandins are now known to inhibit adrenocorticotropic hormone (ACTH) and also to stimulate TSH, GH and LH release. GABA, through action with the hypothalamus, has been shown experimentally to influence the level of GH secretion. Clinical evidence supports the experimental findings of the excitatory and inhibitory effects GABA has on GH secretion, dependent on GABA’s site of action within the hypothalamic-pituitary unit. The homeostatic maintenance of the anterior pituitary is crucial to our physiological well being. Increased plasma levels of TSH induce hyperthermia through a mechanism involving increased metabolism and cutaneous vasodilation. Increased levels
Pituitary apoplexy or nonsecretory tumors, which do not produce excessive amounts of hormones; this might explain why the tumor has often gone undetected prior to an episode of apoplexy. The first case description of pituitary apoplexy has been attributed to the American neurologist Pearce Bailey in 1898. This was followed in 1905 by a further report from the German physician Bleibtreu. Surgery for pituitary apoplexy was described in 1925. Before the introduction of steroid replacement, the mortality from pituitary apoplexy approximated 50%. The name of the condition was coined in 1950 in a case series by physicians from Boston City Hospital and